On October 31, Bian Zhenjia, the Deputy Director of the State Food and Drug Administration came to YRPG Pharmaceutical Group for investigation and inspection. Lu Peimin, Vice Mayor of Taizhou, Chen Guanhua, Director of the Municipal Food and Drug Administration, and Xu Jingren accompanied.
Bian Zhenjia and his delegation deeply inspected the Group's automatic solid warehouse that has been classified as the country's war-prepared medical materials and storage base, as well as the solid reagent preparation workshop and the quality inspection center, to carry out detailed understanding of manufacturing, testing and warehousing processes of pharmaceutical products. Subsequently, Bian Zhenjia also had great interest to come to the construction site of the Pharmaceutical Technology Park, carefully asked about the construction planning of the park, and entered the workshop of oral solution that was installing the equipment to inspect and have a cordial conversation with the employees. Xu Jingren said that the oral solution workshop would soon manufacture the Chinese medicine Lanqin oral solution, which was designated by the Ministry of Health as the drug of choice for the prevention of foot and mouth disease and with a strong market demand. Under a situation where the prices of the raw materials increase and the production profits are impaired, the Group still remains fully committed to guarantee the quality and ensure the market supply. Bian Zhenjia expressed his appreciation to the fact that YRPG Pharmaceutical Group always adheres to the concepts of technical innovation and favoring people by quality.
In the meeting discussions, Xu Jingren briefly reported about the enterprise's development process, technical innovation, quality assurance and new products research and development situation. Bian Zhenjia happily said, "a few years ago I came to YRPG, and this time I come and notice that the enterprise has had a very big change and a good development momentum. YRPG is a flagship of the pharmaceutical manufacturing industry, not only has played an important role in the promotion of the pharmaceutical economic development, but also made a great contribution China's pharmaceutical and healthcare undertaking."
Bian Zhenjia's purpose of this trip was to research the pharmaceutical economic development situation of Taizhou. He expressed that as the Drug Administration Department, it was necessary to provide a good service for the enterprises' development, help enterprises to standardize their manufacture and business activities, while enterprises are needed to fully understand and fully support. At the same time, he sincerely hoped that YRPG could provide more valuable advices and suggestions. The regulatory departments will seriously take into consideration, and will continuously improve and enhance the medicine supervision working method and level, making joint efforts to ensure the quality and safety of the medicines. He encouraged YRPG Pharmaceutical Group to bravely assume the mission and the responsibilities to become bigger and stronger, and make greater contributions to the revitalization of the national medicine and to the benefit of the human health.